These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7819593)

  • 1. Mast cells and fibroblasts: two interacting cells.
    Rubinchik E; Levi-Schaffer F
    Int J Clin Lab Res; 1994; 24(3):139-42. PubMed ID: 7819593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of coculture of rodent mast cells with murine chronic graft-versus-host disease (cGVHD)-derived fibroblasts.
    Levi-Schaffer F; Segal V; Baram D; Mekori YA
    J Allergy Clin Immunol; 1992 Feb; 89(2):501-9. PubMed ID: 1371296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
    Levi-Schaffer F; Segal V; Barak V; Rubinchik E; Nagler A
    Exp Hematol; 1997 Mar; 25(3):238-45. PubMed ID: 9091300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat bone marrow-derived mast cells co-cultured with 3T3 fibroblasts in the absence of T-cell derived cytokines require stem cell factor for their survival and maintain their mucosal mast cell-like phenotype.
    MacDonald AJ; Thornton EM; Newlands GF; Galli SJ; Moqbel R; Miller HR
    Immunology; 1996 Jul; 88(3):375-83. PubMed ID: 8774353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low c-kit expression of cultured mast cells of mi/mi genotype may be involved in their defective responses to fibroblasts that express the ligand for c-kit.
    Ebi Y; Kanakura Y; Jippo-Kanemoto T; Tsujimura T; Furitsu T; Ikeda H; Adachi S; Kasugai T; Nomura S; Kanayama Y
    Blood; 1992 Sep; 80(6):1454-62. PubMed ID: 1381628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts.
    Nagler A; Segal V; Slavin S; Levi-Schaffer F
    Clin Exp Immunol; 1995 Jun; 100(3):529-35. PubMed ID: 7539727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast Cell and Fibroblast Functional Activity Are Affected by Immunocompetent Cells in Chronic Grafts-vs.-Host Disease.
    Levi-Schaffer F; Segal V; Nagler A
    Int Arch Allergy Immunol; 1992; 99(2-4):238-241. PubMed ID: 34167208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term cultures of mast cells: a new model for studying the allergic response.
    Levi-Schaffer F; Shalit M
    Pharmacol Res; 1991 Dec; 24(4):307-17. PubMed ID: 1725209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogeny of in vitro-differentiated mouse mast cells.
    Stevens RL; Rothenberg ME; Levi-Schaffer F; Austen KF
    Fed Proc; 1987 Apr; 46(5):1915-9. PubMed ID: 3549363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in phospholipid composition of mouse bone marrow-derived mast cells during cultivation with fibroblasts.
    Murakami M; Kudo I; Inoue K
    Biochim Biophys Acta; 1992 Feb; 1124(1):17-22. PubMed ID: 1543721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 inhibits 3T3 fibroblast proliferation.
    Rubinchik E; Levi-Schaffer F
    Life Sci; 1996; 58(18):1509-17. PubMed ID: 8649180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological evidence for chronic mast cell activation after prolonged exposure with supernatants from chronic graft-versus-host splenocytes.
    Levi-Schaffer F; Segal V; Mekori YA; Claman HN; Hammel I
    Immunol Lett; 1991 Jan; 27(1):13-8. PubMed ID: 2019417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine release from mouse and rat mast cells cultured with supernatants from chronic murine graft-vs-host splenocytes.
    Levi-Schaffer F; Mekori YA; Segal V; Claman HN
    Cell Immunol; 1990 Apr; 127(1):146-58. PubMed ID: 1690607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated mast cells are fibrogenic for 3T3 fibroblasts.
    Levi-Schaffer F; Rubinchik E
    J Invest Dermatol; 1995 Jun; 104(6):999-1003. PubMed ID: 7769271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutual phenotypic changes between connective tissue type and mucosal mast cells.
    Kitamura Y; Kanakura Y; Sonoda S; Asai H; Nakano T
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):244-8. PubMed ID: 2437040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in irradiation susceptibility and turnover between mucosal and connective tissue-type mast cells of mice.
    Fukuzumi T; Waki N; Kanakura Y; Nagoshi J; Hirota S; Yoshikawa K; Kitamura Y
    Exp Hematol; 1990 Aug; 18(7):843-7. PubMed ID: 2379550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of Mature (Peritoneum-Derived) Mast Cells and Immature (Bone Marrow-Derived) Mast Cell Precursors from Mice.
    Meurer SK; Neß M; Weiskirchen S; Kim P; Tag CG; Kauffmann M; Huber M; Weiskirchen R
    PLoS One; 2016; 11(6):e0158104. PubMed ID: 27337047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound.
    Levi-Schaffer F; Kupietzky A
    Exp Cell Res; 1990 May; 188(1):42-9. PubMed ID: 2328776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of mast cell-derived histamine in the closure of an in vitro wound.
    Kupietzky A; Levi-Schaffer F
    Inflamm Res; 1996 Apr; 45(4):176-80. PubMed ID: 8741007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive proliferation of mature connective-tissue type mast cells in vitro.
    Nakahata T; Kobayashi T; Ishiguro A; Tsuji K; Naganuma K; Ando O; Yagi Y; Tadokoro K; Akabane T
    Nature; 1986 Nov 6-12; 324(6092):65-7. PubMed ID: 3491321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.